Combination of Diosmetin With Chrysin Against Hepatocellular Carcinoma Through Inhibiting <scp>PI3K</scp>/<scp>AKT</scp>/<scp>mTOR</scp>/<scp>NF</scp>‐<scp>кB</scp> Signaling Pathway: <scp>TCGA</scp> Analysis, Molecular Docking, Molecular Dynamics, In Vitro Experiment
Yu Xiang(Bayer (United States)), Lingyun Xu(Wuhan Polytechnic University), Chengming Hu(Wuhan Polytechnic University), Di Zhang(Nanjing Tech University), Li Yang(Chinese Academy of Medical Sciences & Peking Union Medical College), Cheng Fang(SciencePharma (Poland)), Zhinan Mei(Huazhong Agricultural University), Zejun Yu(Wuhan Polytechnic University), Yinsheng Qiu(Wuhan Polytechnic University)
Cited by 2
Related Papers
Receptor binding and complex structures of human ACE2 to spike RBD from omicron and delta SARS-CoV-2
|Cell|2022|538
Preparation of selective organ-targeting (SORT) lipid nanoparticles (LNPs) using multiple technical methods for tissue-specific mRNA delivery
|Nature Protocols|2022|499
AG-221, a First-in-Class Therapy Targeting Acute Myeloid Leukemia Harboring Oncogenic <i>IDH2</i> Mutations
|Cancer Discovery|2017|457
Zwitterionic Phospholipidation of Cationic Polymers Facilitates Systemic mRNA Delivery to Spleen and Lymph Nodes
|Journal of the American Chemical Society|2021|161
The Current Developments in Medicinal Plant Genomics Enabled the Diversification of Secondary Metabolites’ Biosynthesis
|International Journal of Molecular Sciences|2022|60